Objective: To estimate the excess length of stay in an intensive care unit (ICU) due to a central line-associated bloodstream infection (CLABSI), using a multistate model that accounts for the timing of infection.
Design: A cohort of 3,560 patients followed up for 36,806 days in ICUs.
Setting: Eleven ICUs in 3 Latin American countries: Argentina, Brazil, and Mexico.
Patients: All patients admitted to the ICU during a defined time period with a central line in place for more than 24 hours.
Results: The average excess length of stay due to a CLABSI increased in 10 of 11 ICUs and varied from -1.23 days to 4.69 days. A reduction in length of stay in Mexico was probably caused by an increased risk of death due to CLABSI, leading to shorter times to death. Adjusting for patient age and Average Severity of Illness Score tended to increase the estimated excess length of stays due to CLABSI.
Conclusions: CLABSIs are associated with an excess length of ICU stay. The average excess length of stay varies between ICUs, most likely because of the case-mix of admissions and differences in the ways that hospitals deal with infections.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1086/656593 | DOI Listing |
JACS Au
January 2025
Key Laboratory for Water Quality and Conservation of the Pearl River Delta, Ministry of Education, Institute of Environmental Research at Greater Bay, Guangzhou University, Guangzhou 510006, China.
Slow mass transfer processes between inert emerging contaminants (ECs) and dissolved oxygen (DO) limit natural water self-purification; thus, excessive energy consumption is necessary to achieve ECs removal, which has become a longstanding global challenge. Here, we propose an innovative water self-purification expansion strategy by constructing asymmetric surfaces that could modulate trace HO as trigger rather than oxidant to bridge a channel between inert ECs and natural dissolved oxygen, achieved through a dual-reaction-center (DRC) catalyst consisting of Cu/Co lattice-substituted ZnO nanorods (CCZO-NRs). During water purification, the bond lengths of emerging contaminants (ECs) adsorbed on the asymmetric surface were stretched, and this stretching was further enhanced by HO mediation, resulting in a significant reduction of bond-breaking energy barriers.
View Article and Find Full Text PDFFuture Oncol
January 2025
uHuntsman Cancer Institute (NCI-CCC), University of Utah, Salt Lake City, UT, USA.
Bioengineered
December 2025
Department of Biotechnology, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, India.
Polyhydroxyalkanoates (PHA) are bioplastics produced by few bacteria as intracellular lipid inclusions under excess carbon source and nutrient-deprived conditions. These polymers are biodegradable and resemble petroleum-based plastics. The rising environmental concerns have increased the demand for PHA, but the low yield in wild-type bacterial strains limits large-scale production.
View Article and Find Full Text PDFAm J Sports Med
January 2025
Department of Orthopedics and Traumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Background: A discoid lateral meniscus (DLM) is the most common meniscus variant and is commonly treated with arthroscopic saucerization. There are mixed data regarding long-term results after surgery, especially in terms of radiological parameters.
Purpose/hypothesis: The aim was to evaluate the functional and radiological results of patients who underwent arthroscopic saucerization for a symptomatic DLM.
J Cardiothorac Vasc Anesth
January 2025
Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA.
Vasoplegia is a pathophysiologic state of hypotension in the setting of normal or high cardiac output and low systemic vascular resistance despite euvolemia and high-dose vasoconstrictors. Vasoplegia in heart, lung, or liver transplantation is of particular interest because it is common (approximately 29%, 28%, and 11%, respectively), is associated with adverse outcomes, and because the agents used to treat vasoplegia can affect immunosuppressive and other drug metabolism. This narrative review discusses the pathophysiology, risk factors, and treatment of vasoplegia in patients undergoing heart, lung, and liver transplantation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!